58 research outputs found

    Cultural variability in the effects of question design features on respondent comprehension

    Full text link
    Um Charakteristika gleicher Fragen in Gesundheitsumfragen im Zusammenhang mit interkulturellen Unterschieden im Verständnis dieser Fragen zu identifizieren, analysieren die Verfasser Befragungen zum Gesundheitssystem, wobei die Befragten vier verschiedene kulturelle Subgruppen in den USA repräsentieren (weiße Nicht-Hispanics, Afroamerikaner, mexikanische Amerikaner und Puerto Ricaner) mit Hilfe des Instruments des Behaviour Coding. Untersucht werden die Auswirkungen von vier Merkmalen der Fragebogenkonstruktion auf kulturelle Schwierigkeiten beim Verständnis der Fragen. Die empirische Datenbasis bilden 13514 Antworten von 345 Befragten auf 42 Fragen. Es zeigt sich, dass das Antwortformat, die Länge der Frage sowie das Lese- und Abstraktionsniveau der Fragen einen wesentlichen Einfluss auf das Verständnis der Fragen bei den Befragten haben. Die Kultur der Befragen hatte einen moderierenden Einfluss auf die Effekte von Antwortformat, Fragenlänge und Leseniveau. Verschiedene Aspekte des Fragebogendesigns, die den Fragebogen allgemein verständlicher machen sollen, haben ebenfalls kulturspezifische Auswirkungen. (ICEÜbers

    Dynamics of Decadal Climate Variability and Implications for its Prediction

    Get PDF
    The temperature record of the last 150 years is characterized by a long-term warming trend, with strong multidecadal variability superimposed. The multidecadal variability is also seen in other (societal important) parameters such as Sahel rainfall or Atlantic hurricane activity. The existence of the multidecadal variability makes climate change detection a challenge, since Global Warming evolves on a similar timescale. The ongoing discussion about a potential anthropogenic signal in the Atlantic hurricane activity is an example. A lot of work was devoted during the last years to understand the dynamics of the multidecadal variability, and external as well as internal mechanisms were proposed. This White Paper focuses on the internal mechanisms relevant to the Atlantic Multidecadal Oscillation/Variability (AMO/V) and the Pacific Decadal Oscillation/Variability (PDO/V). Specific attention is given to the role of the Meridional Overturning Circulation (MOC) in the Atlantic. The implications for decadal predictability and prediction are discussed

    Instrumentos de avaliação do aleitamento materno e seu uso na prática clínica

    Get PDF
    RESUMO Objetivos Identificar instrumentos de avaliação da amamentação e sua aplicação na prática clínica, validação e adaptação transcultural. Método Revisão integrativa, realizada em seis bases de dados e em uma biblioteca eletrônica, entre agosto/2014-dezembro/2015, sem limitação temporal. Resultados Foram identificados 19 instrumentos de avaliação do AM. Destes, 12 foram validados e cinco foram adaptados transculturalmente. Quanto à aplicação, destacam-se seu uso para a avaliação do risco de desmame (BAPT) e a percepção/comportamento da mulher em amamentar (BSES-SF e IIFAS). Conclusão A identificação dos instrumentos disponíveis e de suas indicações para a avaliação do AM pode auxiliar profissionais na escolha pelo instrumento a ser utilizado, qualificando a assistência materno-infantil

    Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

    Get PDF
    BACKGROUND: Patients with atherosclerotic vascular disease remain at high risk for cardiovascular events despite effective statin-based treatment of low-density lipoprotein (LDL) cholesterol levels. The inhibition of cholesteryl ester transfer protein (CETP) by anacetrapib reduces LDL cholesterol levels and increases high-density lipoprotein (HDL) cholesterol levels. However, trials of other CETP inhibitors have shown neutral or adverse effects on cardiovascular outcomes. METHODS: We conducted a randomized, double-blind, placebo-controlled trial involving 30,449 adults with atherosclerotic vascular disease who were receiving intensive atorvastatin therapy and who had a mean LDL cholesterol level of 61 mg per deciliter (1.58 mmol per liter), a mean non-HDL cholesterol level of 92 mg per deciliter (2.38 mmol per liter), and a mean HDL cholesterol level of 40 mg per deciliter (1.03 mmol per liter). The patients were assigned to receive either 100 mg of anacetrapib once daily (15,225 patients) or matching placebo (15,224 patients). The primary outcome was the first major coronary event, a composite of coronary death, myocardial infarction, or coronary revascularization. RESULTS: During the median follow-up period of 4.1 years, the primary outcome occurred in significantly fewer patients in the anacetrapib group than in the placebo group (1640 of 15,225 patients [10.8%] vs. 1803 of 15,224 patients [11.8%]; rate ratio, 0.91; 95% confidence interval, 0.85 to 0.97; P=0.004). The relative difference in risk was similar across multiple prespecified subgroups. At the trial midpoint, the mean level of HDL cholesterol was higher by 43 mg per deciliter (1.12 mmol per liter) in the anacetrapib group than in the placebo group (a relative difference of 104%), and the mean level of non-HDL cholesterol was lower by 17 mg per deciliter (0.44 mmol per liter), a relative difference of -18%. There were no significant between-group differences in the risk of death, cancer, or other serious adverse events. CONCLUSIONS: Among patients with atherosclerotic vascular disease who were receiving intensive statin therapy, the use of anacetrapib resulted in a lower incidence of major coronary events than the use of placebo. (Funded by Merck and others; Current Controlled Trials number, ISRCTN48678192 ; ClinicalTrials.gov number, NCT01252953 ; and EudraCT number, 2010-023467-18 .)
    corecore